142 related articles for article (PubMed ID: 5527169)
41. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
[No Abstract] [Full Text] [Related]
42. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. I. The action on the central nervous system in rodents.
Metysová J; Metys J
Act Nerv Super (Praha); 1971; 13(3):185-6. PubMed ID: 5165408
[No Abstract] [Full Text] [Related]
43. Comparison of 12-chloroscoulerine enantiomers on animal behavior to dopamine receptors.
Chen LJ; Zhou QT; Dong ZJ; Yu LP; Jin GZ
Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):884-8. PubMed ID: 11270985
[TBL] [Abstract][Full Text] [Related]
44. Neuroleptic action of clozapine injected into various brain areas in rats.
Fog R
Int Pharmacopsychiatry; 1975; 10(2):89-93. PubMed ID: 1170144
[TBL] [Abstract][Full Text] [Related]
45. Reactions to apomorphine and spiroperidol of rats with striatal lesions: the relevance of kind and size of the lesion.
Wolfarth S
Pharmacol Biochem Behav; 1974; 2(2):181-6. PubMed ID: 4597891
[No Abstract] [Full Text] [Related]
46. Amygdala modulation of multiple memory systems: hippocampus and caudate-putamen.
Packard MG; Teather LA
Neurobiol Learn Mem; 1998 Mar; 69(2):163-203. PubMed ID: 9619995
[TBL] [Abstract][Full Text] [Related]
47. Does a true qualitative difference exist in the mode of action of neuroleptics and thymanaleptics on catecholamine neuron systems.
Moller Nielsen I
Mod Probl Pharmacopsychiatry; 1970; 5():68-70. PubMed ID: 5527172
[No Abstract] [Full Text] [Related]
48. Sulman FG: Mammotropic and neuroleptic effects of butyrophenones in the rat.
Mishkinsky J; Khazen K; Givant Y; Dikstein S
Arch Int Pharmacodyn Ther; 1969 May; 179(1):94-105. PubMed ID: 5388566
[No Abstract] [Full Text] [Related]
49. [Pharmacology of catatonigenic substances. 6. Conclusion].
Stille G
Arzneimittelforschung; 1971 Jul; 21(7):997-1003. PubMed ID: 5109518
[No Abstract] [Full Text] [Related]
50. N-substituted analogues of neuroleptics of the octoclothepin series: relations between structure and activity.
Protiva M; Jílek JO; Metysová J
Act Nerv Super (Praha); 1971; 13(3):184-5. PubMed ID: 5165407
[No Abstract] [Full Text] [Related]
51. [Activating component in the effect of tranquilizing agents of the benzdiazepin series].
Vikhliaev IuI; Klygul' TA
Farmakol Toksikol; 1971; 34(3):268-72. PubMed ID: 5568682
[No Abstract] [Full Text] [Related]
52. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
Janssen PA; Allewijn FT
Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
[No Abstract] [Full Text] [Related]
53. Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system.
Muller P; Seeman P
J Pharm Pharmacol; 1974 Dec; 26(12):981-4. PubMed ID: 4156868
[No Abstract] [Full Text] [Related]
54. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
[TBL] [Abstract][Full Text] [Related]
55. Influence of chemical cerebral sympathectomy on behavioural effects of acetylcholine and neuroleptics in rats.
Herman ZS; Brus R; Sokola A; Kostman F
Acta Med Pol; 1975; 16(2):93-100. PubMed ID: 1146609
[No Abstract] [Full Text] [Related]
56. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
Mao L; Wang JQ
Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
[TBL] [Abstract][Full Text] [Related]
57. Brain areas associated with bulbocapnine catalepsy.
Tseng LF; Wei E; Loh HH
Eur J Pharmacol; 1973 Jun; 22(3):363-6. PubMed ID: 4738904
[No Abstract] [Full Text] [Related]
58. [Behavioral activation developing after cessation of electrical stimulation of the caudate nucleus].
Shishliannikova LV
Fiziol Zh SSSR Im I M Sechenova; 1980 Aug; 66(8):1165-70. PubMed ID: 7191378
[TBL] [Abstract][Full Text] [Related]
59. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
[TBL] [Abstract][Full Text] [Related]
60. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
